GNOM News and Press, Global X Genomics & Biotechnology ETF From 05/20/25

2025-05-20 04:00:00 ET Summary The current administration’s economic policies — particularly on trade — appear to be worsening the growth/inflation trade-off. I expect to start seeing the impact of tariffs between late May and early July. If you’re ...

2025-05-19 20:45:00 ET Summary Contrary to what the buoyant stock market might be indicating, this combination of trade policy uncertainty and unusually high import tariff levels does not bode well for this year’s US economic outlook. The only trade agreement that has been ...

2025-05-12 22:35:00 ET Summary Last Thursday, President Trump said “buy.” Investors saluted, clicked, and positioned for a trade breakthrough. On Monday, they got one. Stocks exploded Monday on word that US-China tariffs will fall sharply for at least 90 days. Th...

2025-05-02 03:25:00 ET Summary As global markets digest the recent tariff news and economic and geopolitical uncertainty grow, we’re seeing investors continue to rotate out of cyclical names and into less risky assets, like staples, utilities, healthcare and gold. Looking a...

2025-04-30 04:35:00 ET Summary Fast-changing US government policies have shaken up the global trade system, making it hard for companies and investors to forecast earnings. In any crisis, some companies are directly exposed to the biggest risks, others are not. Investors shoul...

2025-04-24 07:14:00 ET Summary Sweden announced plans to increase its defense spending by $30 billion, aiming to allocate to 3.5% of its GDP to defense by 2030, up from 2.4% currently. Nvidia introduced the Blackwell Ultra and Vera Rubin, its most powerful AI chips to date, amid e...

2025-04-24 07:14:00 ET Summary Sweden announced plans to increase its defense spending by $30 billion, aiming to allocate to 3.5% of its GDP to defense by 2030, up from 2.4% currently. Nvidia introduced the Blackwell Ultra and Vera Rubin, its most powerful AI chips to date, amid e...

2025-04-23 05:45:00 ET Summary The rewiring of global trade is not a temporary disruption, but a structural shift with enduring implications. Rising tariffs, export controls, and investment restrictions are reconfiguring established trade and investment patterns. Regional manu...

2025-04-20 11:28:23 ET Summary The iShares Genomics Immunology and Healthcare ETF is invested in 49 companies involved in genomics, immunology and bioengineering. Compared with the biotechnology benchmark IBB, IDNA has value characteristics, but has greatly underperformed, losing ...

2025-04-04 08:30:00 ET Summary In this episode of the MoneyShow MoneyMasters Podcast, we break down what tariffs could mean for the markets and your portfolio. Stephanie Link, Chief Investment Strategist at Hightower Advisors, and Kathryn Vera, Chief Investment Strategist at Stone...